Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma - A retrospective multi-center cohort study.
Alessa FischerSimon KloosHanna RemdeUlrich DischingerChristina PamporakiHenri J L M TimmersMercedes RobledoStephanie M J FliednerKatharina WangJulian MaurerAstrid ReulNicole BechmannConstanze HantelHermine MohrNatalia S PellegataStefan R BornsteinMatthias KroissChristoph J AuernhammerMartin ReinckeKarel PacakAshley B GrossmanFelix BeuschleinSvenja NöltingPublished in: European journal of endocrinology (2023)
We demonstrate in a real-life clinical setting that all current therapies show reasonable efficacy in preventing disease progression, and this is equally true for patients with germline SDHB mutations.